Wall Street PR

News Update: Ecosphere Technologies, Inc. (OTCQB:ESPH); CGI Group Inc. (USA) (NYSE:GIB); Advaxis, Inc. (NASDAQ:ADXS)

Boston, MA 10/09/2014 (wallstreetpr) – Manufacturing firm, Ecosphere Technologies, Inc. (OTCQB:ESPH), announced on 8th October that it has completed the manufacturing and handing over of a innovative water treatment system called Ozonix® EF10M to Brasil Clean Energy. Brasil Clean Energy is a company which has been championing the cause of clean and sustainable usage of the environment. It has also been granted a license recently to represent Ecosphere in Brazil. In July of this year, the technology firm had indicated that it has entered into a contract with Brasil Clean Energy to supply the water treatment plant and help set it up in Brazil.

CGI Group Inc. (USA) (NYSE:GIB) announced on 8th October that it has inaugurated a state-of-the-art Security Operations Center in U.K. The fully equipped operation centre is situated in South Wales and is to be operated on a 24X7 availability basis. The centre will be offering real time monitoring and proactive treat interception functionalities to its paying customers. The technology firm has both in house as well as cloud based solutions which are sold to its customers as a service. The firm has also indicated that its Reading facility would be positioned as a pay per use service provider to clients who are keen to launch an “advanced threat investigation service.” The new centre would help its customers stay current with the stringent regulatory requirements related to securing customer data.

Clinical-stage bio tech firm Advaxis Inc. (NASDAQ:ADXS), announced on 8th October that it has appointed Dr. Samir N. Khleif as a director and invited him to join the Company’s Board of Directors. Dr. Khleif is a veteran of the biotech sector and has behind him nearly 20 years of R & D experience in cancer cure study. In his welcome statement to the new director, company President and Chief Executive Officer Daniel J. O’Connor expressed his delight at having Dr. Khelif on board of his company. He expressed confidence that Dr. Khleif intimate knowledge of its in house developed “Lm-LLO cancer immunotherapy” treatment process is a great advantage.

Published by Steve Hackney

Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.